Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Wiewrodt

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Neuro-Oncology Advances|May 12, 2025
Blood group O attributes to prolonged progression-free survival, overall survival, and 5-year survival in isocitrate dehydrogenase-wildtype glioblastoma patients with MGMT promoter methylationRainer Wiewrodt, Maren Kloss, Johanna Jost-Engl, et al.
Cancer Research|March 26, 2009
A key regulatory role of the transcription factor NFATc2 in bronchial adenocarcinoma via CD8+ T lymphocytesJoachim H Maxeiner, Roman Karwot, Kerstin Sauer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2014
Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal diseasePetra Hoffknecht, Amanda Tufman, Thomas Wehler, et al.
Emerging Microbes & Infections|September 9, 2024
Molecular characterisation of influenza B virus from the 2017/18 season in primary models of the human lung reveals improved adaptation to the lower respiratory tractDuygu Merve Çalışkan, Sriram Kumar, Saskia Hinse, et al.
Cancer Gene Therapy|April 30, 2003
Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killingRainer Wiewrodt, Kunjlata Amin, Michael Kiefer, et al.
Cancers|April 3, 2021
Quality of Life in Brain Tumor Patients and Their Relatives Heavily Depends on Social Support Factors during the COVID-19 PandemicFabian M Troschel, Franziska Ahndorf, Lisa-Marie Wille, et al.
Blood|January 25, 2002
Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cellsRainer Wiewrodt, Anu P Thomas, Luca Cipelletti, et al.
Canadian Respiratory Journal|March 4, 2022
Sustained Impairment in Cardiopulmonary Exercise Capacity Testing in Patients after COVID-19: A Single Center ExperienceGeorg Evers, Arik Bernard Schulze, Irina Osiaevi, et al.
The American Journal of Pathology|March 14, 2002
Vascular immunotargeting of glucose oxidase to the endothelial antigens induces distinct forms of oxidant acute lung injury: targeting to thrombomodulin, but not to PECAM-1, causes pulmonary thrombosis and neutrophil transmigrationMelpo Christofidou-Solomidou, Stephen Kennel, Arnaud Scherpereel, et al.
Plos One|December 11, 2012
Mutations of the EPHB6 receptor tyrosine kinase induce a pro-metastatic phenotype in non-small cell lung cancerEtmar Bulk, Jun Yu, Antje Hascher, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Neuro-Oncology Advances|May 12, 2025
Blood group O attributes to prolonged progression-free survival, overall survival, and 5-year survival in isocitrate dehydrogenase-wildtype glioblastoma patients with MGMT promoter methylationRainer Wiewrodt, Maren Kloss, Johanna Jost-Engl, et al.
Cancer Research|March 26, 2009
A key regulatory role of the transcription factor NFATc2 in bronchial adenocarcinoma via CD8+ T lymphocytesJoachim H Maxeiner, Roman Karwot, Kerstin Sauer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2014
Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal diseasePetra Hoffknecht, Amanda Tufman, Thomas Wehler, et al.
Emerging Microbes & Infections|September 9, 2024
Molecular characterisation of influenza B virus from the 2017/18 season in primary models of the human lung reveals improved adaptation to the lower respiratory tractDuygu Merve Çalışkan, Sriram Kumar, Saskia Hinse, et al.
Cancer Gene Therapy|April 30, 2003
Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killingRainer Wiewrodt, Kunjlata Amin, Michael Kiefer, et al.
Cancers|April 3, 2021
Quality of Life in Brain Tumor Patients and Their Relatives Heavily Depends on Social Support Factors during the COVID-19 PandemicFabian M Troschel, Franziska Ahndorf, Lisa-Marie Wille, et al.
Blood|January 25, 2002
Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cellsRainer Wiewrodt, Anu P Thomas, Luca Cipelletti, et al.
Canadian Respiratory Journal|March 4, 2022
Sustained Impairment in Cardiopulmonary Exercise Capacity Testing in Patients after COVID-19: A Single Center ExperienceGeorg Evers, Arik Bernard Schulze, Irina Osiaevi, et al.
The American Journal of Pathology|March 14, 2002
Vascular immunotargeting of glucose oxidase to the endothelial antigens induces distinct forms of oxidant acute lung injury: targeting to thrombomodulin, but not to PECAM-1, causes pulmonary thrombosis and neutrophil transmigrationMelpo Christofidou-Solomidou, Stephen Kennel, Arnaud Scherpereel, et al.
Plos One|December 11, 2012
Mutations of the EPHB6 receptor tyrosine kinase induce a pro-metastatic phenotype in non-small cell lung cancerEtmar Bulk, Jun Yu, Antje Hascher, et al.
Pageof 7